Detailed view for PBANKA_1334600

Basic information

TDR Targets ID: 828475
Plasmodium berghei, diacylglycerol kinase, putative
Source Database / ID: 

pI: 9.522 | Length (AA): 457 | MW (Da): 52273 | Paralog Number: 0

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0

Druggability Group : DG

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF00609   Diacylglycerol kinase accessory domain
PF00781   Diacylglycerol kinase catalytic domain

Gene Ontology

Mouse over links to read term descriptions.
GO:0016301   kinase activity  
GO:0004143   diacylglycerol kinase activity  
GO:0003951   NAD+ kinase activity  
GO:0008152   metabolic process  
GO:0007205   activation of protein kinase C activity  
GO:0007165   signal transduction  

Structural information

Modbase 3D models:

There are 3 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
22 378 4wzs (C) 439 775 14.00 0 0.81 0.734582 0.89
51 121 4yy0 (B) 375 452 18.00 0 0.01 0.291761 -0.83
131 175 2bon (A) 61 104 50.00 0.35 0.64 0.383168 1

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Upper 80-100% percentile 4 hs Ring. Otto TD
Upregulation Percent Ranking Stage Dataset
Upper 60-80% percentile Erthyrocytic stages. Yeoh LM
Upregulation Percent Ranking Stage Dataset
Mid 40-60% percentile Gametocyte, 16 hs Trophozoite, 22 hs Schizont, Female gametocyte. Otto TD Yeoh LM
Upregulation Percent Ranking Stage Dataset
Lower 20-40% percentile Ookinete, Male gametocyte. Otto TD Yeoh LM
Show/Hide expression data references
  • Otto TD A comprehensive evaluation of rodent malaria parasite genomes and gene expression.
  • Yeoh LM Comparative transcriptomics of female and male gametocytes in Plasmodium berghei and the evolution of sex in alveolates.

Orthologs

Ortholog group members (OG5_137829)

Species Accession Gene Product
Babesia bovis BBOV_III004760   diacylglycerol kinase, putative
Cryptosporidium hominis Chro.40493   hypothetical protein
Cryptosporidium parvum cgd4_4340   diacylglycerol kinase
Neospora caninum NCLIV_022470   diacylglycerol kinase, putative
Plasmodium berghei PBANKA_1334600   diacylglycerol kinase, putative
Plasmodium falciparum PF3D7_1471400   diacylglycerol kinase, putative
Plasmodium knowlesi PKNH_1209600   diacylglycerol kinase, putative
Plasmodium vivax PVX_116900   diacylglycerol kinase, putative
Plasmodium yoelii PY06359   diacylglycerol kinase variant A
Toxoplasma gondii TGME49_202460   diacylglycerol kinase accessory domain (presumed) domain-containing protein
Theileria parva TP02_0475   diacylglycerol kinase, putative

Essentiality

PBANKA_1334600 has direct evidence of essentiality
Gene/Ortholog Organism Phenotype Source Study
PBANKA_1334600 this record Plasmodium berghei Slow plasmo
TGME49_202460 Toxoplasma gondii Probably essential sidik
Show/Hide essentiality data references
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets
Obtained from network model
No druggable targets predicted through repurposing network model

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier PBANKA_1334600 (Plasmodium berghei), diacylglycerol kinase, putative
Title for this comment
Comment